Download PDF
Planta Med 2010; 76(15): 1635-1641
DOI: 10.1055/s-0030-1250120
Reviews
© Georg Thieme Verlag KG Stuttgart · New York

1,5-Anhydro-D-Fructose and its Derivatives: Biosynthesis, Preparation and Potential Medical Applications[*]

Roland Fiskesund1 , Kazuhiro Abeyama2 , 3 , Kazuhiro Yoshinaga4 , Jun-ichi Abe5 , Yongbing Yuan6 , Shukun Yu7
  • 1Department of Medicine, Unit of Emergency Medicine, Karolinska Institute, Huddinge, Stockholm, Sweden
  • 2Taikai Clinic, Chugo Satsuma-Sendai, Japan
  • 3Department of Functional Biology and Pharmacology, Kagoshima University, Sakuragaoka, Kagoshima, Japan
  • 4R & D Division, Nihon Denpun, Ltd. Kagoshima, Japan
  • 5Department of Bioscience and Technology, Faculty of Agriculture, Kagoshima University, Kagoshima, Japan
  • 6Laboratory of Biorenew and Applied Enzymology, Qingdao Agricultural University, Qingdao, China
  • 7Enzyme R & D, Genencor Division, Danisco A/S, Aarhus, Denmark
Further Information

Publication History

received May 9, 2010 revised June 5, 2010

accepted June 14, 2010

Publication Date:
19 July 2010 (online)

   Permissions and Reprints

Abstract

1,5-Anhydro-D-fructose (AF) was first found in fungi and red algae. It is produced by the degradation of glycogen, starch and maltosaccharides with α-1,4-glucan lyase (EC 4.2.2.13). In vivo, AF is metabolized to 1,5-anhydro-D-glucitol (AG), ascopyrone P (APP), microthecin and other derivatives via the anhydrofructose pathway. The genes coding for the enzymes in this pathway have been cloned, enabling the large-scale production of AF and related products in a cell-free reactor. The possible applications of these products in medicine have been evaluated using both in vitro and in vivo systems. Thus AF is a useful anticariogenic agent as it inhibits the growth of the oral pathogen Streptococcus mutans, impairing the production of plaque-forming polysaccharides and lactic acid. AF also shows anti-inflammatory and anticancer effects. AG is used as a diabetic marker for glycemic control. AG also stimulates insulin secretion in insulinoma cell lines. In vivo, APP has been shown to lengthen the life span of cancer-afflicted mice. It interferes with tumor growth and metastasis by its cidal effects on fast multiplying cells. Microthecin inhibits the growth of the human pathogen Pseudomonas aeruginosa PAO1, particularly under anaerobic conditions. The pharmaceutical usefulness of the other AF metabolites 1,5-anhydro-D-mannitol,1-deoxymannojirimycin, haliclonol, 5-epipentenomycin I, bissetone, palythazine, isopalythazine, and clavulazine remains to be investigated. In this review AF and its metabolites as the bioactive natural products for their pharmaceutical potentials are discussed.

Key words

1,5‐anhydro‐D‐fructose - anhydrofructose pathway - anticancer activity - diabetes - inflammation - dental care - morels - red algae

1 Dedication Dedicated to Professor Inge Lundt, Department of Chemistry, Technical University of Denmark

References

  • 1 Drew D P, Krichau N, Reichwald K, Simonsen H T. Guaianolides in apiaceae: perspectives on pharmacology and biosynthesis.  Phytochem Rev. 2009;  8 581-599
    CrossrefPubMedGoogle Scholar
  • 2 Yu S, Fiskesund R. The anhydrofructose pathway and its possible role in stress response and signaling.  Biochim Biophys Acta. 2006;  1760 1314-1322
    PubMedGoogle Scholar
  • 3 Yu S. The anhydrofructose pathway.  IUBMB Life. 2008;  60 798-809
    CrossrefPubMedGoogle Scholar
  • 4 Yu S. α-1,4-Glucan lyase, a new starch processing enzyme for production of 1,5-anhydro-D-fructose.  Zuckerindustrie. 2004;  129 26-30
    PubMedGoogle Scholar
  • 5 Yu S, Andreassen M, Lundt I. Enzymatic production of microthecin by aldos-2-ulose dehydratase from 1,5-anhydro-D-fructose and stability studies of microthecin.  Biocatal Biotransformation. 2008;  26 169-176
    CrossrefPubMedGoogle Scholar
  • 6 Yoshinaga K, Wakamatsu C, Saeki Y, Abe J I, Hizukuri S. Conversion of 1,5-anhydro-D-fructose into functional compound, ascopyrone P by heating.  J Appl Glycosci. 2005;  52 287-291
    CrossrefPubMedGoogle Scholar
  • 7 Hisaku S, Takeda Y, Abe J I, Muroya T, Yoshinaga K, Fujisue M (Hizukuri). Agent for suppressing or inhibiting bacterial proliferation containing 1,5-anhydro-D-fructose. Jap Patent Appl JP11-266336. 1999
    PubMedGoogle Scholar
  • 8 Hisaku S, Fujisue M, Abe J I (Hizukuri). Prophylactic for tooth disease and method for producing food containing the same. Jap Patent Appl JP2004123604. 2004
    PubMedGoogle Scholar
  • 9 Abeyama K, Yoshimoto Y. Antitumor agent. Eur Patent Appl EP1686122. 2006
    PubMedGoogle Scholar
  • 10 Deffieux G, Baute R, Baute M A, Atfani M, Carpy A. 1,5-Anhydro-D-fructose, the precursor of the pyrone microthecin in Morchella vulgaris.  Phytochemistry. 1987;  26 1391-1393
    CrossrefPubMedGoogle Scholar
  • 11 Yu S, Kenne L, Pedersén M. α-1,4-Glucan lyase, a new class of starch/glycogen degrading enzyme. I. Efficient purification and characterization from red seaweeds.  Biochim Biophys Acta. 1993;  1156 313-320
    PubMedGoogle Scholar
  • 12 Yu S, Christensen T M I E, Kragh K M, Bojsen K, Marcussen J. Efficient purification, characterization and partial amino acid sequencing of two α-1,4-glucan lyases from fungi.  Biochim Biophys Acta. 1997;  1339 311-320
    CrossrefPubMedGoogle Scholar
  • 13 Baute M A, Baute R, Deffieux G. Fungal enzymatic activity degrading 1,4-α-D-glucans to 1,5-D-anhydrofructose.  Phytochemistry. 1988;  27 3401-3403
    CrossrefPubMedGoogle Scholar
  • 14 Baute M A, Deffieux G, Vercauteren J, Baute R, Badoc A. Enzymic activity degrading 1,4-α-glucans to ascopyrones P and T in Pezizales and Tuberales.  Phytochemistry. 1993;  33 41-45
    CrossrefPubMedGoogle Scholar
  • 15 Suzuki M, Mizuno H, Akanuma Y, Akanuma H. Synthesis of 1,5-anhydro-D-glucitol from glucose in rat hepatoma cells.  J Biochem (Tokyo). 1994;  115 87-92
    PubMedGoogle Scholar
  • 16 Suzuki M, Kametani S, Uchida K, Akanuma H. Production of 1,5-anhydroglucitol from 1,5-anhydrofructose in erythroleukemia cells.  Eur J Biochem. 1996;  240 23-29
    CrossrefPubMedGoogle Scholar
  • 17 Kametani S, Shiga Y, Akanuma H. Hepatic production of 1,5-anhydrofructose and 1,5-anhydroglucitol in rat by the third glycogenolytic pathway.  Eur J Biochem. 1996;  242 832-838
    CrossrefPubMedGoogle Scholar
  • 18 Shiga Y, Kametani S, Kadokura T, Akanuma H. 1,5-Anhydroglucitol promotes glycogenolysis in Escherichia coli.  J Biochem (Tokyo). 1999;  125 166-172
    PubMedGoogle Scholar
  • 19 Broberg A, Kenne L, Pedersén M. Analysis of 1,5-anhydro-D-fructose, microthecin, and 4-deoxy-glycero-hexo-2,3-diulose in algae using gas chromatography-mass spectrometry in selected ion monitoring mode.  Anal Biochem. 1999;  268 35-42
    CrossrefPubMedGoogle Scholar
  • 20 Andersen S M, Lundt I, Marcussen J, Yu S. 1,5-Anhydro-D-fructose, a versatile chiral building block: biochemistry and chemistry.  Carbohydr Res. 2002;  337 873-890
    CrossrefPubMedGoogle Scholar
  • 21 Yu S, Marcussen J. α-1,4-Glucan lyase, molecular features and its use for production of 1,5-anhydro-D-fructose from starch. Gilbert HJ, Davies GJ, Henrissat B, Svensson B Recent advances in carbohydrate bioengineering. London; Royal Society of Chemistry (RS.C) Press 1999: 243-250
    PubMedGoogle Scholar
  • 22 Dekany G, Lundt I, Niedermair F, Bichler S, Spreitz J, Sprenger F K, Stütz A E. 1,5-Anhydro-D-fructose from D-fructose.  Carbohydr Res. 2007;  342 1249-1253
    CrossrefPubMedGoogle Scholar
  • 23 Lundt I, Yu S. 1,5-Anhydro-D-fructose: biocatalytic and chemical synthetic methods for the preparation, transformation and derivatization.  Carbohydr Res. 2010;  345 181-190
    CrossrefPubMedGoogle Scholar
  • 24 Andersen S M, Jensen H M, Yu S. Ascopyrone P: chemical synthesis from D-glucose.  J Carbohydr Chem. 2002;  21 569-578
    CrossrefPubMedGoogle Scholar
  • 25 Kühn A, Yu S, Giffhorn F. Catabolism of 1,5-anhydro-D-fructose in Sinorhizobium morelense S-30.7.5: discovery, characterization, and overexpression of a new 1,5-anhydro-D-fructose reductase and its application in sugar analysis and rare sugar synthesis.  Appl Environ Microbiol. 2006;  72 1248-1257
    CrossrefPubMedGoogle Scholar
  • 26 Andersen S M, Lundt I, Marcussen J. 1,5-Anhydro-D-fructose: stereoselective conversions to 1,5-anhydroalditols and deoxy/amino substituted analogues.  J Carbohydr Chem. 2000;  19 717-725
    CrossrefPubMedGoogle Scholar
  • 27 Maier P, Andersen S M, Lundt I. 1,5-Anhydro-D-fructose as a chiral building block: a novel approach to 1-deoxymannojirimycin.  Synthesis. 2006;  827-830
    Article in Thieme ConnectPubMedGoogle Scholar
  • 28 Deffieux G, Vercauterena J, Baute M A, Neveu A, Baute R. Bacterial conversion of the fungal ascopyrone T to 2(S)-dihydroascopyrone T (haliclonol).  Phytochemistry. 1994;  36 849-852
    CrossrefPubMedGoogle Scholar
  • 29 Baute M A, Deffieux G, Baute R, Badoc A, Vercauteren J, Léger J M, Neveu A. Fungal enzymic activity degrading 1,4-α-D-glucans to echinosporin (5-epipentenomycin I).  Phytochemistry. 1991;  30 1419-1423
    CrossrefPubMedGoogle Scholar
  • 30 Brehm M, Göckel V H, Jarglis P, Lichtenthaler F W. Expedient conversion of D-glucose into 1,5-anhydro-D-fructose and into single stereogenic-center dihydropyranones, suitable six-carbon scaffolds for concise syntheses of the soft-coral constituents (−)-bissetone and (−)-palythazine.  Tetrahedron Asym. 2008;  19 358-373
    CrossrefPubMedGoogle Scholar
  • 31 Cardellina J H, Hendrickson R L, Manfredi K P, Strobel S A, Clardy J. Bissetone, a unique antimicrobial pyranone from the gorgonian Briareu polyanthes.  Tetrahedron Lett. 1987;  28 727-730
    CrossrefPubMedGoogle Scholar
  • 32 Taguchi T, Haruna M, Okuda J. Effects of 1,5-anhydro-D-fructose on selected glucose-metabolizing enzymes.  Biotechnol Appl Biochem. 1993;  18 275-283
    PubMedGoogle Scholar
  • 33 Ferrari R A, Mandelstam P, Crane R K. 1,5-Anhydro-D-glucitol 6-phosphate and its use for the specific inhibition of the hexokinase reaction in tissue homogenates.  Arch Biochem Biophys. 1959;  80 372-377
    CrossrefPubMedGoogle Scholar
  • 34 Keston A S. Mutarotase inhibition by L-deoxyglucose.  Science. 1964;  143 698-700
    CrossrefPubMedGoogle Scholar
  • 35 Carabaza A, Ciudad C J, Baqué S, Guinovart J J. Glucose has to be phosphorylated to activate glycogen synthase, but not to inactivate glycogen phosphorylase in hepatocytes.  FEBS Lett. 1992;  296 211-214
    CrossrefPubMedGoogle Scholar
  • 36 Yamanouchi T, Inoue T, Ichiyanagi K, Sakai T, Ogata N. 1,5-Anhydroglucitol stimulates insulin release in insulinoma cell lines.  Biochim Biophys Acta. 2003;  1623 82-87
    PubMedGoogle Scholar
  • 37 Yamanouchi T, Ogata N, Yoshimura T, Inoue T, Ogata E, Kawasaki T, Kashiwabara A, Muraoka H. Transport of 1,5-anhydro-D-glucitol into insulinoma cells by a glucose-sensitive transport system.  Biochim Biophys Acta. 2000;  1474 291-298
    PubMedGoogle Scholar
  • 38 Abeyama K, Yoshimoto Y, Nagayama S. Adiponectin production promoting agent. Jap Patent Appl JP2008195630. 2008
    PubMedGoogle Scholar
  • 39 Yamanouchi T, Tachibana Y, Akanuma H, Minoda S, Shinohara T, Moromizato H, Miyashita H, Akaoka I. Origin and disposal of 1,5-anhydroglucitol, a major polyol in the human body.  Am J Physiol. 1992;  263 E268-E273
    PubMedGoogle Scholar
  • 40 Yabuuchi M, Masuda M, Katoh K, Nakamura T, Akanuma H. Simple enzymatic method for determining 1,5-anhydro-D-glucitol in plasma for diagnosis of diabetes mellitus.  Clin Chem. 1989;  35 2039-2043
    PubMedGoogle Scholar
  • 41 Yamaji K, Sarker K P, Maruyama I, Hizukuri S. Antioxidant effects of 1,5-anhydro-D-fructose, a new natural sugar, in vitro.  Planta Med. 2002;  68 16-19
    Article in Thieme ConnectPubMedGoogle Scholar
  • 42 Yuan Y B, Cao R, Westh B, Yu S. Examination of 1,5-anhydro-D-fructose and the enolone ascopyrone P, metabolites of the anhydrofructose pathway of glycogen and starch degradation, for their possible application in fruits, vegetables and beverages as antibrowning agents.  J Agric Food Chem. 2005;  53 9491-9497
    CrossrefPubMedGoogle Scholar
  • 43 Yu S, Pedersén M, Kenne L. Glucan lyase producing 1,5-anhydrofructose. US Patent Appl US5695970. 1997
    PubMedGoogle Scholar
  • 44 Yajima M, Furuhashi S, Muroya T, Yoshinaga K, Fujisue M. Method for preventing discoloration of noodle and noodle quality improver. Jap Patent Appl JP 2003047416. 2003
    PubMedGoogle Scholar
  • 45 Lee O, Bruce W R, Dong Q, Bruce J, Mehta R, O'Brien P J. Fructose and carbonyl metabolites as endogenous toxins.  Chem Biol Interact. 2009;  178 332-339
    CrossrefPubMedGoogle Scholar
  • 46 Abeyama K, Maruyama Y, Yoshimoto Y, Yoshinaga K. Anti-inflammatory agent. Jap Patent Appl JP2006306814. 2006
    PubMedGoogle Scholar
  • 47 Meng X J, Kawahara K I, Nawa Y, Miura N, Shrestha B, Tancharoen S, Sameshima H, Hashiguchi T, Maruyama I. 1,5-Anhydro-D-fructose attenuates lipopolysaccharide-induced cytokine release via suppression of NF-κB p 65 phosphorylation.  Biochem Biophys Res Commun. 2009;  380 343-348
    CrossrefPubMedGoogle Scholar
  • 48 Meng X J, Kawahara K I, Matsushita K, Nawa Y, Shrestha B, Kikuchi K, Sameshima H, Hashiguchi T, Maruyama I. Attenuation of LPS-induced iNOS expression by 1,5-anhydro-D-fructose.  Biochem Biophys Res Commun. 2009;  387 42-46
    CrossrefPubMedGoogle Scholar
  • 49 Yu S, Mei J, Ahrén B. Basic toxicology and metabolism studies of 1,5-anhydro-D-fructose using bacteria, cultured mammalian cells and rodent models.  Food Chem Toxicol. 2004;  42 1677-1686
    PubMedGoogle Scholar
  • 50 Mei J, Yu S, Ahrén B. A 90-day toxicological evaluation of 1,5-anhydro-D-fructose in Sprague-Dawley rats.  Drug Chem Toxicol. 2005;  28 263-272
    CrossrefPubMedGoogle Scholar
  • 51 Thomas L V, Ingram R E, Yu S, Delves-Broughton J. Investigation of the effectiveness of ascopyrone P as a food preservative.  Int J Food Microbiol. 2004;  93 319-323
    CrossrefPubMedGoogle Scholar
  • 52 Fiskesund R, Thomas L V, Schobert M, Ernberg I, Lundt I, Yu S. Inhibition spectrum studies of microthecin and other anhydrofructose derivatives using selected strains of gram-positive and -negative bacteria, yeasts and moulds, and investigation of the cytotoxicity of microthecin to malignant blood cell lines.  J Appl Microbiol. 2009;  106 624-633
    CrossrefPubMedGoogle Scholar
  • 53 Brown J M, Wilson W R. Exploiting tumour hypoxia in cancer treatment.  Nat Rev Cancer. 2004;  4 437-447
    CrossrefPubMedGoogle Scholar
  • 54 Morgan A J, Turner M, Yu S, Weiergang I, Pedersen H C. Antimicrobial formulation comprising microthecin or derivatives thereof and their uses in prevention and therapy. Int Patent Appl WO2004083226. 2004
    PubMedGoogle Scholar
  • 55 Merlet D, Mellado M, Deffieux G, Baute M A, Cambar J. Cytotoxic effect of biogenetically related pyrone and cyclopentenone fungal metabolites on renal cell line (LLC-PK1).  Bull Soc Pharm Bordeaux. 1991;  130 5-16
    PubMedGoogle Scholar
  • 56 Bojsen K, Yu S, Kragh K M, Marcussen J. A group of α-1,4-glucan lyases and their genes from the red alga Gracilariopsis lemaneiformis: purification, cloning, and heterologous expression.  Biochim Biophys Acta. 1999;  1430 396-402
    CrossrefPubMedGoogle Scholar
  • 57 Yoshinaga K, Fujisue M, Abe J I, Hanashiro I, Takeda Y, Muroya K, Hizukuri S. Characterization of exo-(1,4)-α glucan lyase from red alga Gracilaria chorda. Activation, inactivation and the kinetic properties of the enzyme.  Biochim Biophys Acta. 1999;  1472 447-454
    PubMedGoogle Scholar
  • 58 Bojsen K, Yu S, Marcussen J. A family of α-1,4-glucan lyase genes from fungi. Cloning, complete sequencing, and heterologous expression.  Plant Mol Biol. 1999;  40 445-454
    CrossrefPubMedGoogle Scholar
  • 59 Yu S, Refdahl C, Lundt I. Enzymatic description of the anhydrofructose pathway of glycogen degradation. I. Identification and purification of anhydrofructose dehydratase, ascopyrone tautomerase and α-1,4-glucan lyase in the fungus Anthracobia melaloma.  Biochim Biophys Acta. 2004;  1672 120-129
    PubMedGoogle Scholar

1 Dedication Dedicated to Professor Inge Lundt, Department of Chemistry, Technical University of Denmark

Roland Fiskesund, MD

Department of Medicine
Unit of Emergency Medicine
Karolinska Institute, Huddinge

SE-171 77 Stockholm

Sweden

Phone: +46 7 02 65 04 77

Email: roland.fiskesund@ki.se

      >